Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence
about
Evidence for novel hepaciviruses in rodentsEffectiveness of needle/syringe programmes and opiate substitution therapy in preventing HCV transmission among people who inject drugsStatus of HIV and hepatitis C virus infections among prisoners in the Middle East and North Africa: review and synthesisConceptual framework for outcomes research studies of hepatitis C: an analytical reviewSafety and efficacy of daclatasvir in the management of patients with chronic hepatitis CSafety and Efficacy of Adding Ribavirin to Interferon or Peginterferon in Treatment of Hepatitis C Infection in Patients With Thalassemia: A Systematic Review on Randomized Controlled TrialsInterferon-Free Treatments for Chronic Hepatitis C Genotype 1 InfectionHepatitis C virus and neurological damageHepatitis C virus/human T lymphotropic virus 1/2 co-infection: Regional burden and virological outcomes in people who inject drugsKASL clinical practice guidelines: management of hepatitis CHepatoprotective Effects of Chinese Medicinal Herbs: A Focus on Anti-Inflammatory and Anti-Oxidative ActivitiesHepatitis VaccinesInterferon Lambda 4 Polymorphism Predicts Sustained Viral Response in Hepatitis C Virus Patients Irrespective of Hepatitis C Virus Genotypes, Ethnicity or Treatment Regimen: Results From a Meta-AnalysisHepatitis C virus relies on lipoproteins for its life cycleHepatitis C Virus Epidemiology in Djibouti, Somalia, Sudan, and Yemen: Systematic Review and Meta-AnalysisGenetic Markers of the Host in Persons Living with HTLV-1, HIV and HCV InfectionsChaperones in hepatitis C virus infectionControversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinomaHepatitis C in non-hepatic solid organ transplant candidates and recipients: A new horizonSignificance of hepatitis virus infection in the oncogenic initiation of hepatocellular carcinomaMicroRNA-mediated interactions between host and hepatitis C virusVertically acquired hepatitis C virus infection: Correlates of transmission and disease progressionMechanisms of Hepatitis C Viral Resistance to Direct Acting AntiviralsOxidative Stress and Inflammation in Hepatic Diseases: Therapeutic Possibilities of N-AcetylcysteineChronic hepatitis C: This and the new era of treatmentTransmission of Hepatitis B and C Virus Infection Through Body Piercing: A Systematic Review and Meta-AnalysisUpdate on hepatitis C: Direct-acting antiviralsHepatitis C genotype 4: The past, present, and futureStrategies for treating chronic HCV infection in patients with cirrhosis: latest evidence and clinical outcomesRoles of lipoprotein receptors in the entry of hepatitis C virusEra of direct acting antivirals in chronic hepatitis C: Who will benefit?The Seroprevalence of Hepatitis C Antibodies in Immigrants and Refugees from Intermediate and High Endemic Countries: A Systematic Review and Meta-AnalysisRibavirin contributes to eradicate hepatitis C virus through polarization of T helper 1/2 cell balance into T helper 1 dominanceSystematic review with meta-analysis: direct comparisons of biomarkers for the diagnosis of fibrosis in chronic hepatitis C and BGenetic, metabolic and environmental factors involved in the development of liver cirrhosis in MexicoGAMMA GLUTAMYLTRANSFERASE IMPACT IN THERAPEUTIC RESPONSE OF CHRONIC HEPATITIS C: a systematic review of the literatureChronic Hepatitis C Infection in Children: Current Treatment and New TherapiesThe prevalence of hepatitis C among healthcare workers: a systematic review and meta-analysisTreatment of Hepatitis C Virus Infection in Children Less than 12 Years of Age in Developing CountriesInjecting drug use: A vector for the introduction of new hepatitis C virus genotypes
P2860
Q21089595-0C76E729-DEC4-45AD-9543-C16D29AA4CB2Q24186785-151DCD9E-F04B-4B4D-BBD8-0FFE5D5CCF07Q26745482-83EC32BF-E0D4-4852-A03D-7F59D1B2C70EQ26745582-4AD92E67-9263-4F31-B0B4-7E5A080A7743Q26745769-F6A3AA1D-5630-41E1-BA77-16E0462CB0EEQ26745895-D8987EEC-4A4D-45A5-9379-563CF2B59689Q26746563-0E5C4343-74C2-46DB-AACC-192115332FC6Q26748575-43131559-9F3F-4D39-B759-5FC31FEC2F12Q26749788-76A10587-4B97-413E-B341-399A921D6897Q26752471-0E3F2A9F-CFFB-4D96-8AA5-C6E864FA77FBQ26752622-1DD2D812-D6C7-4084-A04E-8202E63BF910Q26765433-D775F8C8-26E2-4013-B577-52D53EE156BCQ26765752-2242589C-FD41-44C6-A75F-2C07051BD014Q26766119-4B65FA3D-0997-4998-8F75-239ABBF0234FQ26768490-3E4D147C-A591-4340-8A45-94467E85CB3DQ26768628-398BC124-B81E-4BFF-AE63-208082DC891DQ26771251-5D230462-F9A4-4325-A66F-41D6CDFA3321Q26772324-B730BD6A-BBEB-4E45-A962-43FF32920191Q26773201-76933F4F-8AA6-4A33-8FA0-D8B08BE6FC89Q26773251-F0B3B022-07DC-4627-BACA-98B5B9103C12Q26773254-2C03E4F6-8D2C-4FEF-8ACA-3E65C301EF40Q26773285-7385BC2D-7EB0-414A-BF33-2574927F9152Q26773321-45729F94-8BBF-4821-8794-CECA1E6E3D91Q26773384-17852AE3-BF01-4D74-A48E-B86203699CCCQ26775011-A2771C6C-0ED1-49DA-8066-D0208E5BB6BAQ26775165-0004FBC8-6BE7-402E-87C9-4C9804763866Q26775809-CE926EF3-AE66-46B3-A4FF-C2BADBFDC59EQ26775815-48763A82-6530-480B-922B-5CF2904986F2Q26777086-2C7BE157-EC9B-4690-BE3F-AEFC47D33155Q26777338-36BBF980-0E18-4061-A905-9F081514A169Q26777506-47B43867-69D6-4EEB-878A-9016ACAC1F05Q26777560-800BF10A-6208-498A-9B05-380659233B8BQ26777659-B382C2C5-108C-40ED-8B6C-069BF4C8C570Q26777916-C2FD1ECD-247C-4E07-9C42-4C197EDC1C12Q26778035-8CE46213-3A84-43D5-92D9-44737145B955Q26781202-C0EB389C-C491-4401-906C-0ACF17724921Q26781770-B77A4CCA-435C-4095-BB8C-BFCF4A0BAB47Q26781853-FA6D2108-93D2-4D6B-86B5-605EC859C711Q26781890-32F08420-D0AD-4A17-897B-4F6824187B21Q26781991-058E64A8-081B-41F4-98C0-E01ED28B1FA2
P2860
Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Global epidemiology of hepatit ...... antibody to HCV seroprevalence
@ast
Global epidemiology of hepatit ...... antibody to HCV seroprevalence
@en
type
label
Global epidemiology of hepatit ...... antibody to HCV seroprevalence
@ast
Global epidemiology of hepatit ...... antibody to HCV seroprevalence
@en
prefLabel
Global epidemiology of hepatit ...... antibody to HCV seroprevalence
@ast
Global epidemiology of hepatit ...... antibody to HCV seroprevalence
@en
P2093
P31
P921
P3181
P356
P1433
P1476
Global epidemiology of hepatit ...... antibody to HCV seroprevalence
@en
P2093
Flaxman AD
Mohd Hanafiah K
Wiersma ST
P304
P3181
P356
10.1002/HEP.26141
P407
P577
2013-04-01T00:00:00Z